The Kitasato Institute, Tokyo 108, Japan (Received for publication April 4, 1996) During the past three decades numerous analogues o: lincomycin1} (1, lincocin) and related antibiotics, sucr as celesticetin2) (2) have been prepared3) by synthetic anc microbiological transformation, involving modificatior of the parent antibiotics both at the sugar moiety anc the amino acid side-chain ( Fig. 1 ). Of these new derivatives 7(S)-chloro-7-deoxylincomycin4) (3, cleocin, clindamycin) is one of the most important, possessing mon pronounced and wider spectrum of antibiotic activity, a* well as enhanced absorption capability than lincomycir (1) .
The present paper describes our results on the chemica modification of clindamycin (3) . During our work c primary goal was to perform syntheses of the new antibiotic analogues which do not require temporary protection of the existing functions of the starting molecules. Nucleophilic substitution of the 7(S)-chlorine atom ol 3 offers the synthesis of novel antibiotic analogues modified at position C-7 (Fig. 2) . By employing sodiuir azide (4a) and various heteroaromatic mercapto compounds (4b~4e) and DMFas the solvent 7-azido-7-deoxylincomycin (5a) and the 7-thioether derivatives 5b~5e were obtained probably with inversion of the configuration.
In the latter cases fused potassium carbonate was used as the acid scavenger. In the above newcompoundsthe steric position of the introduced R2 substituent is equal with that of the C-7 hydroxyl group of 1. However an opposite C-7 chirality can not be excluded on the basis on NMR-spectroscopic6) evidences.
Selected physico-chemical properties and spectroscopic data of 5a~5e are listed in Table 1 . Table 2 shows the in vitro antibacterial activity of the 7-substituted lincomycins.
The exchange of the C-7
hydroxyl group of 1 to an azido function with the same Method: Agar dilution method. Solvents: Dist. water (1, 3) ; 30% MeOH (5b); 50% MeOH (5a, 5c, 5d); DMSO-H2O (7:3) (5e). MHA: Mueller Hinton agar (Nissui) 37°C, 20 hours. GAM: GAMAgar Nissui, 37°C, 23 hours. Gas pack method (BBL).
configuration retained the order of magnitude of the clindamycin, antimicrobial activity. The azido compound (5a) possesses higher activity towards the microorganisms in entries 4 and 5 than 1. but these effects are still lower Experimental than those of 3. Of the new antibiotic analogues having Meltingpoints were determined with a Kofler hot-stage a heteroaryl-thio group at C-7 compound5b is almost apparatus and are uncorrected. *H NMR spectra were as active as lincomycin itself, but it is less effective than recorded at 200MHzon a Bruker WP200 SY spec- 7-Azido-7-deoxylincomycin (5a) A mixture of 3 (0.25mmol) and sodium azide (2.5mmol) in abs. DMF(5ml) was stirred at 100°C for 18 hours and the progress of reaction was monitored by TLC (A). When all of the starting 3 had reacted the reaction mixture was filtered, the filter-cake was washed with chloroform and the combined filtrate was concentrated and co-distilled with toluene under diminished pressure. The residue was purified with the aid of column chromatography (A).
7-Heteroaryl-thio-lincomycins (5b~5e) A mixture of3 (1 mmol), 4b~4f(1.1 mmol) and freshly fused and well-powdered potassium carbonate (2.2 mmol) in abs. DMF (8ml) was stirred at 100~10.5°C for 24~36 hours. After filtration the filtrate was concentrated and co-distilled with toluene under diminished 943 pressure. The crude products (5b~5e)
were then submitted to column chromatography (eluent to furnish pure): 5b (B), 5c (C), 5d (D) and 5e (E).
